K Number
K151139
Device Name
EasyMap MAP Catheter
Date Cleared
2016-10-18

(538 days)

Product Code
Regulation Number
870.1220
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
EasyMap MAP catheters are indicated for simultaneously pacing and recording Monophasic Action Potentials (MAPs) from the endocardial surface of the human heart.
Device Description
EasyMap MAP is a single-use disposable quadropolar catheter for recording monophasic action potentials and for intracardial pacing. Integrated in the catheter tip are a Silver-Chloride Electrode (AgCI), a Silver Electrode (Ag) and two orthogonally placed Silver Electrodes (Ag). These electrodes enable mapping of cardiac electrochemical potentials. The catheter tip can be deflected in a single direction up to 270 degrees.
More Information

Not Found

No
The summary describes a physical catheter with electrodes for recording and pacing, with no mention of AI/ML, image processing, or data analysis beyond basic signal recording.

No
The device is indicated for pacing and recording monophasic action potentials, which are diagnostic or monitoring functions, not therapeutic.

Yes
The EasyMap MAP catheter records Monophasic Action Potentials (MAPs) and maps cardiac electrochemical potentials to assess the heart's electrical activity, which is a diagnostic function.

No

The device description explicitly states it is a "single-use disposable quadropolar catheter" with integrated electrodes, indicating it is a physical hardware device.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections. They are used to provide information for diagnosis, monitoring, or screening.
  • Device Function: The EasyMap MAP catheter is used to directly interact with the endocardial surface of the human heart. It records electrical signals (Monophasic Action Potentials) and can also be used for pacing. This is an in vivo procedure, meaning it is performed within the living body.
  • Intended Use: The intended use clearly states "simultaneously pacing and recording Monophasic Action Potentials (MAPs) from the endocardial surface of the human heart." This is a direct interaction with the heart tissue, not a test performed on a sample taken from the body.

Therefore, the EasyMap MAP catheter falls under the category of a medical device used for diagnosis and treatment within the body, not an in vitro diagnostic device.

N/A

Intended Use / Indications for Use

EasyMap MAP catheters are indicated for simultaneously pacing and recording Monophasic Action Potentials (MAPs) from the endocardial surface of the human heart.

Product codes (comma separated list FDA assigned to the subject device)

DRF

Device Description

EasyMap MAP is a single-use disposable quadropolar catheter for recording monophasic action potentials and for intracardial pacing. Integrated in the catheter tip are a Silver-Chloride Electrode (AgCl), a Silver Electrode (Ag) and two orthogonally placed Silver Electrodes (Ag). These electrodes enable mapping of cardiac electrochemical potentials. The catheter tip can be deflected in a single direction up to 270 degrees.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

human heart

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Cardiac EP or cardiovascular surgeons

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Performance Based upon the documentation presented in this 510(k) it has been data demonstrated that the EasyMap MAP Catheter is safe and effective for its intended use.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K903880

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 870.1220 Electrode recording catheter or electrode recording probe.

(a)
Identification. An electrode recording catheter or an electrode recording probe is a device used to detect an intracardiac electrocardiogram, or to detect cardiac output or left-to-right heart shunts. The device may be unipolar or multipolar for electrocardiogram detection, or may be a platinum-tipped catheter which senses the presence of a special indicator for cardiac output or left-to-right heart shunt determinations.(b)
Classification. Class II (performance standards).

0

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus symbol, which is a staff with two snakes entwined around it. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the symbol. The logo is black and white.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

October 18, 2016

MedFact Engineering GmbH % Melissa Walker President & Cto Graematter, Inc 1324 Clarkson Clayton Ctr. #332 Ballwin, Missouri 63011

Re: K151139

Trade/Device Name: EasyMap MAP Catheter Regulation Number: 21 CFR 870.1220 Regulation Name: Electrode Recording Catheter or Electrode Recording Probe Regulatory Class: Class II Product Code: DRF Dated: September 11, 2016 Received: September 13, 2016

Dear Melissa Walker:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in

1

the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours.

Mude Jellman
for

Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

2

Indications for Use

510(k) Number (if known) K151139

Device Name EasyMap MAP Catheter

Indications for Use (Describe)

EasyMap MAP catheters are indicated for simultaneously pacing and recording Monophasic Action Potentials (MAPs) from the endocardial surface of the human heart.

Type of Use (Select one or both, as applicable)
☑ Prescription Use (Part 21 CFR 801 Subpart D)☐ Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

Appendix 1: 510(k) Summary per 21CFR §807.92

| Submitter's
information | Jörg Reinhardt
MedFact Engineering GmbH
Hammerstrasse 3
D-79540 Löerrach/ Germany | Contact: Melissa Walker
Graematter, Inc.
1324 Clarkson Clayton Ctr #332
Ballwin, MO 63011
Phone: 636-405-7498
Date: 04/20/2015 |
|-----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------|
| Device/
classification
name | Classification information for the EasyMap MAP Catheter follows:
• 21 CFR 870.1220
• Product Code DRF
• Classification/Common name: Electrode recording catheter or electrode recording probe | |
| | The marketed device(s) to which substantial equivalence is claimed:
• Franz Steerable Combination Catheter 510(k)
K903880 cleared October 12, 1990. | |
| Device
description | EasyMap MAP is a single-use disposable quadropolar catheter for recording
monophasic action potentials and for intracardial pacing. Integrated in the
catheter tip are a Silver-Chloride Electrode (AgCI), a Silver Electrode (Ag)
and two orthogonally placed Silver Electrodes (Ag). These electrodes enable
mapping of cardiac electrochemical potentials. | |
| | The catheter tip can be deflected in a single direction up to 270 degrees. | |
| Indications for
use | EasyMap MAP catheters are indicated for simultaneously pacing and
recording monophasic Action-Potentials (MAPs) from the endocardial surface
of the human heart. | |
| | Continued on next page | |

4

Appendix 1: 510(k) Summary per 21CFR §807.92, Continued

Comparison matrix of basic key characteristics

The table below lists the main characteristics of the proposed EasyMap MAP Catheter compared to the Predicate Franz MAP Catheter. The Franz MAP Catheter was chosen as the predicate device because the intended use is identical to the EasyMap MAP Catheter in that both are designed to detect and record electrical potentials from the endocardial surfaces of the heart and to deliver externally generated pacing stimuli.

| Device Characteristic | Franz Steerable
Combination Catheter
Predicate Device
K903880 | Proposed New Device:
EasyMap MAP
Catheter |
|-------------------------------------------------------|--------------------------------------------------------------------------|-------------------------------------------------------------------------|
| Physiologic purpose | Aid physician in
management of
arrhythmias | same |
| Intended for use by | Cardiac EP or
cardiovascular surgeons | same |
| Primary function | MAP recording and
temporary cardiac pacing | same |
| Insertion method | Percutaneous through a
large vein by Seldinger
technique | same |
| Electrode material | MAP: AG/AgCl
Pacing: Platinum | same |
| No. of electrodes | 4-8 electrodes
2 MAP
2-6 Pacing | 4 electrodes
2 MAP
2 Pacing |
| Electrode spacing - | MAP electrodes
4.5 mm edge to edge | MAP electrodes
4.5 mm edge to edge |
| Image: Diagram of pacing and MAP recording electrodes | Pacing electrodes
3.6 mm (center to center),
1.6 mm (edge to edge) | Pacing electrodes
3.6 mm (center to center)
1.6 mm (edge to edge) |
| Sterile | Yes | same |
| Method of sterilization | EO gas | same |
| Single use | Yes | same |
| Catheter body material | Pebax | Pebax |
| Catheter diameter | 5, 6, 7 F | 7F |
| catheter length | 80-150 cm | 110 cm |
| Tip deflection angle/
range | 270° in two directions | Unidirectional up to 270° |

Continued on next page

5

Appendix 1: 510(k) Summary per 21CFR §807.92, Continued

Test summary The table below lists the applied standards and test results for the EasyMap MAP Catheter.

TestApplied StandardResult
Corrosion TestISO 10555Passed Test
Dimension TestsInternal Test MethodPassed Test
Electrical Tests
  • Continuity
  • Short Circuit
  • Isolation/Leakage Test
  • High Voltage Test (1 kV) | EN 60601 | Passed Test |
    | Mechanical Test
  • Mechanical Strength after moisture storage | ISO 10555 | Passed Test |
    | - Steerability | Internal Test Method | |
    | - Fixation Push / Pull Control | Internal Test Method | |
    | Compatibility with existing products
  • Bending
  • Dimensions | Internal Test Method | Passed Test |
    | Biocompatibility | ISO 10993 | Passed Test |
    | Shelf Life Test | Internal Test Method | Passed Test |
    | Packaging Validation | ISO 11607-1 | Passed Test |
    | Sterilization Validation | EN 550; ISO11135 | Passed Test |
    | X-Ray Test / Visibility | Internal Test Method | Passed Test |

Note: Tests are to be performed on sterilized products after storage and moisture (0.9% NaCl water bath 37 °C, 24 h) Thermal Shock Test and bending performance test.

Performance Based upon the documentation presented in this 510(k) it has been data demonstrated that the EasyMap MAP Catheter is safe and effective for its intended use.